SEC Form 4 · accession 0001576318-15-000002
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hong Zhao
Officer — CEO, China Operations
Period of report
Jun 8, 2015
Accepted (ET)
Jun 9, 2015 · 11:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 10,000 | $4.52 | A | 10,000 | D | |
| Common Stock | Jun 8, 2015 | S | 10,000 | $9.2338 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $4.52 | Jun 8, 2015 | M | 10,000 | D | — | Mar 14, 2024 | Common Stock | 10,000 | 90,000 | D |
Explanation of responses
- F1Granted under the Issuer's 2005 Equity Incentive Plan.
- F225% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.